Crinetics Pharmaceuticals (CRNX) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.38
-1.21
-1.05
-0.88

Details

Expected EPS
-1.244353
Actual EPS
-1.38
Surprise EPS
-0.14
Surprise Percent
+10.9%

Description

Crinetics Pharmaceuticals (CRNX) has reported earnings of -1.38 per share for Q4 2025.

0 Comments

Share your thoughts